MeSH term
Frequency | Condition_Probility | Female | 22 | 0.0 |
Humans | 38 | 0.0 |
Drug Administration Schedule | 2 | 0.0 |
Infusions, Intravenous | 2 | 0.0 |
Male | 25 | 0.0 |
Middle Aged | 18 | 0.0 |
Research Support, Non-U.S. Gov't | 27 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 15 | 0.0 |
Age Factors | 2 | 0.0 |
Aged | 15 | 0.0 |
Aged, 80 and over | 8 | 0.0 |
Hippocampus/*pathology | 8 | 15.0 |
Neurofibrillary Tangles/*pathology | 3 | 13.0 |
Neurons/pathology | 2 | 1.0 |
Animals | 14 | 0.0 |
Analysis of Variance | 4 | 0.0 |
Neurons/*pathology | 2 | 3.0 |
Adult | 9 | 0.0 |
Immunohistochemistry | 7 | 0.0 |
Base Sequence | 2 | 0.0 |
Mice | 3 | 0.0 |
Molecular Sequence Data | 2 | 0.0 |
Rats | 8 | 0.0 |
English Abstract | 2 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Cell Count | 4 | 0.0 |
Schizophrenia/*pathology | 3 | 23.0 |
Tissue Distribution | 3 | 0.0 |
Neurons/*metabolism | 2 | 0.0 |
Binding, Competitive | 2 | 0.0 |
Hippocampus/*metabolism | 2 | 2.0 |
Histocytochemistry | 3 | 0.0 |
Pyramidal Cells/metabolism | 2 | 22.0 |
Alzheimer Disease/*pathology | 3 | 5.0 |
In Situ Hybridization | 4 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Comparative Study | 8 | 0.0 |
Area Under Curve | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Rats, Inbred Strains | 2 | 0.0 |
Hippocampus/pathology/*physiopathology | 2 | 100.0 |
Sclerosis | 3 | 5.0 |
Adolescent | 4 | 0.0 |
Species Specificity | 2 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
*Neuronal Plasticity | 2 | 10.0 |
